Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...
Contineum (CTNM) announced authorization of its investigational new drug, or IND, application from FDA for PIPE-791 for the treatment of chronic pain associated with two separate indications, ...
Anti-inflammatory Diet: How To Reduce Inflammation Through Eating; Know Foods You Can Eat And Avoid Does Brisk Walking Impact Your Knees? Know How To Walk Right To Reduce Symptoms Of Osteoarthritis ...
Good afternoon, everyone. Thank you for joining us today to discuss PetVivo's Results for its Fiscal Second Quarter ended September 30, 2024. Focusing on the call today is our Chief Executive Officer, ...